Filed: 5/2/2023ACC: 0001104659-23-055031
📋 What this filing means
ARBORETUM VENTURES, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $33.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$33.92M
Total AUM (reported)
25.12M
Total Shares
Allocation by class
COM$31.15M91.8%
CLASS A COM$2.77M8.2%
Portfolio Concentration
Top 3$33.92M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 25.12M
Sole
Full voting authority
25.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
EQRX INC
SOLEShares13.94M
TypeSH
Market value$27.04M
79.70%
Sole
13.94M
Shared
0.00
None
0.00
INOGEN INC
SOLEShares330K
TypeSH
Market value$4.12M
12.14%
Sole
330K
Shared
0.00
None
0.00
PEAR THERAPEUTICS INC
SOLEShares10.86M
TypeSH
Market value$2.77M
8.16%
Sole
10.86M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EQRX INCSOLE | COM | 13.94M | SH | $27.04M 79.70% | 13.94M | 0.00 | 0.00 |
INOGEN INCSOLE | COM | 330K | SH | $4.12M 12.14% | 330K | 0.00 | 0.00 |
PEAR THERAPEUTICS INCSOLE | CLASS A COM | 10.86M | SH | $2.77M 8.16% | 10.86M | 0.00 | 0.00 |